Evaluation of preventive efficacy of Irsogladine maleate to stomatitis by Fluoropyrimidine anticancer agent.
Not Applicable
- Conditions
- Stomatitis by anticancer agent.
- Registration Number
- JPRN-UMIN000008810
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with stomatitis and/or oral symptoms before the start of treatment. 2)Patients who are pregnant, suspected to be pregnant or breastfeeding. 3)Patients with drug allergy and/or history of severe side effect due to irsogladine maleate. 4)The patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method